Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of the patients.

From: Corticosteroid-induced spinal epidural lipomatosis in the pediatric age group: report of a new case and updated analysis of the literature

Pt. Age (years) Sex Diagnosis Duration of steroid treat- ment (years) Steroid dose (mg/d) Therapy Clinical outcomea Reference
1 17 (?)b m Kidney transplant 1 40 Surgery SR Improvement Lee 1975 [1]
2 13 m Kidney transplant 1.5 45 SR, diet Resolution George 1983 [5]
3 6 m JIA 4 40 Surgery SR Improvement Perling 1988 [6]
4 11 m Pineoblastoma 1 20 Surgery Progression of symptoms due to spread of tumor Quint 1988 [7]
5 6 m sJIA 1 10-40 Surgery Resolution Arroyo 1988 [8]
6 16 m Kidney transplant 3 0.4/kg SR, diet Resolution Vazquez 1988 [9]
7 10 m NS 0.7 60 SR, diet Improvement Shirai 1990 [10]
8 11 m NS 0.8 12-60 Surgery Improvement Kano 1996 [15]c
9 14 f NS 0.25 24-80 SR Resolution -„-
10 14 m NS 0.4 48-80 SR Resolution -„-
11 10 m HSP 0.8 36-72 SR Resolution -„-
12 8 f Crohn disease 6.5 10-60? SR Died from sepsis Muňoz 2002 [11]
13 14 m SLE 0.8 <60 SR Improvement Miller 2002 [12]
14 5 f NS 1.4 5-60 SR Resolution Kano 2004, 2005 [13, 16]
15 10 f NS 0.4 20-60 SR Resolution Kano 2005 [16]
16 14 f SLE 0.5 0.2/kg SR Resolution Möller 2010 [17]
17 11 f Sjögren syndrome 0.6 0.5/kg SR Resolution Möller 2010 [17]
18 7 f sJIA 1.5 40 SR Resolutiond Möller 2010 [17]
19 12 f Lung transplant 0.06 25 SR, diet Resolution Caruba 2010 [14]
20 10 f Relapsing polychondritis 0.4 30 SR Resolution This report
  1. aImprovement or resolution as interpreted from the authors' reports of symptoms, findings or imaging.
  2. bAge could not be determined accurately, but was more likely 17 than 18 years.
  3. cPatient diagnosed in 1979.
  4. dDied from chronic macrophage activation syndrome 1 year later.
  5. Abbreviations: f, female; HSP, Henoch Schönlein purpura; LE, lower extremity; m, male; n/d, not done or not documented; NS, nephrotic syndrome; sJIA, systemic juvenile idiopathic arthritis; SLE, systemic lupus erythematosus; SR, steroid reduction; UE, upper extremity.